Grand Rounds, April 16, 2025

April 13, 2026

Presentation Title: Surgical Evolution and Long-term Outcomes of Biliary Atresia: From Tohoku University Techniques to National Registry Insights and Linkage Research

Speaker: Motoshi Wada, MD, Pediatric Surgery, Tohoku University Graduate School of Medicine

Date: Thursday, April 16, 2025
Time: 7:00 AM ‐ 8:00 AM
Location: Medical School Building
Learning Format: In‐Person

Learning Objectives:
At the conclusion of this activity, participants should be able to:

  • Describe the key refinements of the Kasai procedure developed at Tohoku University, specifically focusing on porta hepatis dissection at the liver capsule level and the use of anti-reflux spur valves to optimize jaundice clearance.
  • Determine the approach clinical indications for redo Kasai portoenterostomy and apply updated recommendations from the 2nd Edition Japanese Clinical Practice Guidelines for perioperative management.
  • Analyze the log-term survival trends and postoperative complications based on the Japanese Biliary Artesia Registry, which reports a 30-year overall survival rate of 85.7% ad a native liver survival rate of 40.9%

Accreditation Statement: McGovern Medical School at the University of Texas Health Science Center at Houston is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education or physicians.

Credit Designation: McGovern Medical School at the University of Texas Health Science Center at Houston designates this live activity for 1 AMA PRA Category 1 Credit. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

ABS MOC Statement: Successful completion of this CME activity, which includes participation in the evaluation component, enables the learner to earn credit toward the CME and Self-Assessment requirement (s) of the American Board of Surgery’s Continuous Certification program.  It is the CME activity provider’s responsibility to submit learner completion information to ACGME for the purpose of granting ABS credit.

Disclosure of Financial Relationships:

Speaker: Motoshi Wada, MD, Department of Pediatrics, Tohoku University Graduate School of Medicine –  “ Surgical Evolution and Long-term Outcomes of Biliary Atresia: From Tohoku University Techniques to National Registry Insights and Linkage Research”. He has disclosed financial relationship with one or more ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients:

  • Takeda Pharmaceutical Company Limited – Speakers Bureau – Relationship Has Not Ended
  • Takeda Pharmaceutical Company Limited – Consulting – Relationship Has Not Ended

Planners Committee Members: David Wainwright, MD, Sasha D. Adams, MD, Acute Care Surgery Program Director, General Surgery Residency Vice-Chair for Education, Department of Surgery, Lillian Kao, MD, Professor, Surgery, Natalie Drucker, MD and Tamara Saunders, MD have no financial relationship(s) with ineligible companies who primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients to disclose.

Mark Hobeika, MD –  TransMedics, Inc – Contracted Research – Relationship Ended

Steven Canfield, MD – AngioDynamics – Advisory Committee Member – Relationship Has Not Ended

Erik Wilson, MD – Johnson & Johnson – Teaching – Relationship Has Not Ended;  Gore – Teaching – Relationship Has Not Ended; Medtronic – Teaching – Relationship Has Not Ended; GI Windows – Independent Contractor – Relationship Has Not Ended; Boston Scientific – Teaching – Relationship Has Not Ended

Laura Moore, MD – Frontline Medical Technologies – Advisory Committee Member – Relationship Has Not Ended

Shinil Shah, DO – GI Windows – Contracted Research – Relationship Has Not Ended

Any financial relationship that was found to be relevant has been mitigated.

 

Related topics